114 related articles for article (PubMed ID: 35352981)
1. Site-Specific Labeling Reveals Cas9 Induces Partial Unwinding Without RNA/DNA Pairing in Sequences Distal to the PAM.
Li Y; Liu Y; Singh J; Tangprasertchai NS; Trivedi R; Fang Y; Qin PZ
CRISPR J; 2022 Apr; 5(2):341-352. PubMed ID: 35352981
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9 Activities with Truncated 16-Nucleotide RNA Guides Are Tuned by Target Duplex Stability Beyond the RNA/DNA Hybrid.
Li Y; Cooper BH; Liu Y; Wu D; Zhang X; Rohs R; Qin PZ
Biochemistry; 2023 Sep; 62(17):2541-2548. PubMed ID: 37552860
[TBL] [Abstract][Full Text] [Related]
3. A DNA unwinding equilibrium serves as a checkpoint for CRISPR-Cas12a target discrimination.
Singh J; Liu KG; Allen A; Jiang W; Qin PZ
Nucleic Acids Res; 2023 Sep; 51(16):8730-8743. PubMed ID: 37522352
[TBL] [Abstract][Full Text] [Related]
4. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.
Ma E; Harrington LB; O'Connell MR; Zhou K; Doudna JA
Mol Cell; 2015 Nov; 60(3):398-407. PubMed ID: 26545076
[TBL] [Abstract][Full Text] [Related]
5. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.
Sternberg SH; Redding S; Jinek M; Greene EC; Doudna JA
Nature; 2014 Mar; 507(7490):62-7. PubMed ID: 24476820
[TBL] [Abstract][Full Text] [Related]
6. The Impact of DNA Topology and Guide Length on Target Selection by a Cytosine-Specific Cas9.
Tsui TKM; Hand TH; Duboy EC; Li H
ACS Synth Biol; 2017 Jun; 6(6):1103-1113. PubMed ID: 28277645
[TBL] [Abstract][Full Text] [Related]
7. Single-Molecule Insight Into Target Recognition by CRISPR-Cas Complexes.
Rutkauskas M; Krivoy A; Szczelkun MD; Rouillon C; Seidel R
Methods Enzymol; 2017; 582():239-273. PubMed ID: 28062037
[TBL] [Abstract][Full Text] [Related]
8. Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling.
Ivanov IE; Wright AV; Cofsky JC; Aris KDP; Doudna JA; Bryant Z
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5853-5860. PubMed ID: 32123105
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 Mediated DNA Unwinding Detected Using Site-Directed Spin Labeling.
Tangprasertchai NS; Di Felice R; Zhang X; Slaymaker IM; Vazquez Reyes C; Jiang W; Rohs R; Qin PZ
ACS Chem Biol; 2017 Jun; 12(6):1489-1493. PubMed ID: 28437608
[TBL] [Abstract][Full Text] [Related]
10. A DNA Unwinding Equilibrium Serves as a Checkpoint for CRISPR-Cas12a Target Discrimination.
Singh J; Liu KG; Allen A; Jiang W; Qin PZ
bioRxiv; 2023 May; ():. PubMed ID: 37292754
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease.
Anders C; Niewoehner O; Duerst A; Jinek M
Nature; 2014 Sep; 513(7519):569-73. PubMed ID: 25079318
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional Degradation of DNA Cleavage Products Catalyzed by CRISPR/Cas9.
Stephenson AA; Raper AT; Suo Z
J Am Chem Soc; 2018 Mar; 140(10):3743-3750. PubMed ID: 29461055
[TBL] [Abstract][Full Text] [Related]
13. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
14. Structure of the Cpf1 endonuclease R-loop complex after target DNA cleavage.
Stella S; Alcón P; Montoya G
Nature; 2017 Jun; 546(7659):559-563. PubMed ID: 28562584
[TBL] [Abstract][Full Text] [Related]
15. DNA Unwinding Is the Primary Determinant of CRISPR-Cas9 Activity.
Gong S; Yu HH; Johnson KA; Taylor DW
Cell Rep; 2018 Jan; 22(2):359-371. PubMed ID: 29320733
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 searches for a protospacer adjacent motif by lateral diffusion.
Globyte V; Lee SH; Bae T; Kim JS; Joo C
EMBO J; 2019 Feb; 38(4):. PubMed ID: 30573670
[TBL] [Abstract][Full Text] [Related]
17. Structure- and Content-Dependent Efficiency of Cas9-Assisted DNA Cleavage in Genome-Editing Systems.
Baranova SV; Zhdanova PV; Lomzov AA; Koval VV; Chernonosov AA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430368
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for Cas9 off-target activity.
Pacesa M; Lin CH; Cléry A; Saha A; Arantes PR; Bargsten K; Irby MJ; Allain FH; Palermo G; Cameron P; Donohoue PD; Jinek M
Cell; 2022 Oct; 185(22):4067-4081.e21. PubMed ID: 36306733
[TBL] [Abstract][Full Text] [Related]
19. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
[TBL] [Abstract][Full Text] [Related]
20. Engineered CRISPR-Cas9 nuclease with expanded targeting space.
Nishimasu H; Shi X; Ishiguro S; Gao L; Hirano S; Okazaki S; Noda T; Abudayyeh OO; Gootenberg JS; Mori H; Oura S; Holmes B; Tanaka M; Seki M; Hirano H; Aburatani H; Ishitani R; Ikawa M; Yachie N; Zhang F; Nureki O
Science; 2018 Sep; 361(6408):1259-1262. PubMed ID: 30166441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
